| Title |
Ponatinib-3001 data for publish |
| Description |
A Phase 3, Randomized, Open-label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered in Combination With Reduced-Intensity Chemotherapy, in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) result data for publish |
| Organism |
Homo sapiens |
| Data Type |
Other Type of Genomic Data |
| Data Accessibility |
Controlled-access |
| BioProject |
PRJCA016096 |
| Release Date |
2024-03-05 |
| Submitter |
Jingjing Jin (jinjingjing@ihcams.ac.cn) |
| Organization |
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences |
| Submission Date |
2023-04-07 |